Cecilia Mao - Feb 20, 2024 Form 3 Insider Report for EQUIFAX INC (EFX)

Role
EVP, Chief Product Officer
Signature
/s/Lisa Stockard as Attorney-in-Fact
Stock symbol
EFX
Transactions as of
Feb 20, 2024
Transactions value $
$0
Form type
3
Date filed
2/29/2024, 04:09 PM
Previous filing
Feb 12, 2024
Next filing
May 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EFX Common Stock 6.7K Feb 20, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EFX Stock Option/Right to Buy Feb 20, 2024 Common Stock 4.52K $155.05 Direct F2
holding EFX Stock Option/Right to Buy Feb 20, 2024 Common Stock 1.97K $177.19 Direct F3
holding EFX Stock Option/Right to Buy Feb 20, 2024 Common Stock 1.93K $206.16 Direct F4
holding EFX Stock Option/Right to Buy Feb 20, 2024 Common Stock 1.55K $225.00 Direct F5
holding EFX Stock Option/Right to Buy Feb 20, 2024 Common Stock 1.78K $249.18 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
F2 The option vests in three equal annual increments beginning 6/1/2021.
F3 The option vests in three equal annual increments beginning 2/12/2022.
F4 The option vests in three equal annual increments beginning 2/10/2024.
F5 The option vests in three equal annual increments beginning 2/11/2023.
F6 The option vests in three equal annual increments beginning 2/9/2025.

Remarks:

Exhibit 24 - Power of Attorney